financetom
Business
financetom
/
Business
/
Danaher, AstraZeneca Collaborate on Precision Medicine
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Danaher, AstraZeneca Collaborate on Precision Medicine
May 29, 2025 2:24 PM

05:02 PM EDT, 05/29/2025 (MT Newswires) -- Danaher ( DHR ) said late Thursday it is collaborating with AstraZeneca ( AZN ) to scale precision medicine, including developing AI-powered diagnostics.

The partnership would create a framework for diagnostics research, development and commercialization, Danaher ( DHR ) said, adding that it will support the development cycle through its Centers for Enabling Precision Medicine.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Pixie Dust Technologies (PXDT) Stock Is Down 43% Today
Why Pixie Dust Technologies (PXDT) Stock Is Down 43% Today
Oct 25, 2024
Pixie Dust Technologies Inc ( PXDT ) saw its shares plummet 40% to 61 cents Friday afternoon on downward momentum after the company this week announced the voluntary delisting of its ADRs from the NASDAQ Capital Market. Pixie Dust Technologies ( PXDT ) says this move, driven by high costs associated with maintaining the listing and reporting obligations, aims to...
Skechers USA Q3 Shows Breadth of Product Offerings, UBS Says
Skechers USA Q3 Shows Breadth of Product Offerings, UBS Says
Oct 25, 2024
12:51 PM EDT, 10/25/2024 (MT Newswires) -- Skechers USA's ( SKX ) Q3 results showed the strength of its worldwide reach and breadth of product offerings, UBS said in a note Thursday. The firm said it raised its 2024 earnings per share forecast for Skechers to $4.25 from $4.15 primarily due to the company's strong beat in Q3. UBS said...
Annaly Capital Management Q3 Non-GAAP Earnings Are Unchanged
Annaly Capital Management Q3 Non-GAAP Earnings Are Unchanged
Oct 25, 2024
05:09 PM EDT, 10/23/2024 (MT Newswires) -- Annaly Capital Management ( NLY ) reported Q3 non-GAAP earnings late Wednesday of $0.66 per diluted share, unchanged from a year earlier. Analysts polled by Capital IQ expected $0.67. Price: 19.63, Change: +0.08, Percent Change: +0.41 ...
Orangekloud Technology Names Toh Puay-Yong as CFO
Orangekloud Technology Names Toh Puay-Yong as CFO
Oct 25, 2024
12:04 PM EDT, 10/25/2024 (MT Newswires) -- Orangekloud Technology ( ORKT ) said Friday that Toh Puay-Yong has been named chief financial officer, succeeding Shally Ang, who is resigning for personal reasons. Toh has worked at the company since 2017, holding roles in finance, mergers and acquisitions and strategic management, as well as covering the CFO duties from mid-February to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved